Pro Dex Inc Net Income per Employee (PDEX), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Pro dex Inc   (NASDAQ: PDEX)
 

Pro Dex Inc Net Income per Employee

PDEX's Quarterly Results, Trends, Rankings, Statistics
With an income increase of 20.24% in the third quarter 2026, year on year to cumulative value of $12 million, and with 223 employees, Pro Dex Inc 's income per employee grew on trailing twelve month basis to $ 53,821, this marks a new company high for all of 223 employees.
The Healthcare sector has seen employees of 26 other companies achieving higher income per employee. While Pro Dex Inc 's total ranking has deteriorated compared to the previous quarter from 151 to 1314.


What is Income per Employee Ratio?






PDEX Net Income per Employee (Mar 31 2026)
III. Quarter
(Dec 31 2025)
II. Quarter
(Sep 30 2025)
I. Quarter
(Jun 30 2025)
IV. Quarter
(Mar 31 2025)
III. Quarter
Y / Y Net Income Change 20.24 % 7.21 % 89.78 % -24.57 % 400 %
Net Income per Employee (TTM) $ 53,821 50,848 50,188 40,260 42,009
PDEX's Total Ranking # 1314 # 151 # 998 # 1287 # 1292
Seq. Net Income Change 80.06 % -53.27 % 290.98 % -63.45 % 60.54 %


PDEX Net Income per Employee Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 27
Healthcare Sector # 118
Overall Market # 1314

Net Income per Employee Statistics
High Average Low
$ 53,821 $ 16,897 $ -6,973
(Mar 31 2026)   (Sep 30 2013)







Companies with similar Income per Employee for 12 month ending Mar 31 2026, within Healthcare Sector Income per Employee Income 12 month ending Mar 31 2026Number of Employees Mar 31 2026
Dexcom Inc   83,819.82 $ 930.400  Million 11,100 
Biomarin Pharmaceutical Inc  83,434.34 $ 268.742  Million 3,221 
Progyny Inc   79,080.61 $ 67.693  Million 856 
Strata Critical Medical Inc   78,193.01 $ 46.994  Million 601 
Agilent Technologies inc   78,121.55 $ 1,414.000  Million 18,100 
Sarepta Therapeutics Inc   77,912.57 $ 65.057  Million 835 
Aveanna Healthcare Holdings Inc   74,712.57 $ 261.494  Million 3,500 
Alkermes Plc   74,497.56 $ 152.720  Million 2,050 
Medpace Holdings Inc   74,257.74 $ 460.398  Million 6,200 
Solventum Corporation  71,600.00 $ 1,432.000  Million 20,000 
Edwards Lifesciences Corporation  68,356.25 $ 1,093.700  Million 16,000 
Alpha Pro Tech Ltd   68,308.94 $ 8.402  Million 123 
Protalix Biotherapeutics inc   67,840.71 $ 15.332  Million 226 
Corcept Therapeutics Inc  63,946.58 $ 46.681  Million 730 
Abbvie Inc   63,877.19 $ 3,641.000  Million 57,000 
Embecta Corp   60,486.49 $ 111.900  Million 1,850 
Boston Scientific Corporation  60,322.03 $ 3,559.000  Million 59,000 
Stryker Corp  59,589.29 $ 3,337.000  Million 56,000 
Utah Medical Products Inc  59,278.69 $ 10.848  Million 183 
Waters Corporation  56,866.84 $ 449.248  Million 7,900 
Insulet Corporation  56,074.07 $ 302.800  Million 5,400 
Msa Safety Inc  54,827.92 $ 290.588  Million 5,300 
Abbott Laboratories  54,573.91 $ 6,276.000  Million 115,000 
Vericel Corporation  53,924.62 $ 21.462  Million 398 
Pro dex Inc   53,820.63 $ 12.002  Million 223 
Mettler toledo International Inc   52,714.46 $ 875.060  Million 16,600 
Profound Medical Corp   52,123.46 $ 8.444  Million 162 
Electromed Inc   51,289.34 $ 10.104  Million 197 
West Pharmaceutical Services Inc   50,250.00 $ 542.700  Million 10,800 
Sbc Medical Group Holdings Incorporated  47,372.07 $ 40.882  Million 863 


Date modified: 2026-08-30T14:40:01+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.